<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04100499</url>
  </required_header>
  <id_info>
    <org_study_id>187/19</org_study_id>
    <nct_id>NCT04100499</nct_id>
  </id_info>
  <brief_title>Evaluation of Adjunctive EndoAnchors for EVAR and TEVAR</brief_title>
  <official_title>Evaluation of Adjunctive Use of EndoAnchors During of After EVAR and TEVAR</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Ramon y Cajal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario Ramon y Cajal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      EndoAnchors (Heli-FX device, Medtronic, Santa Rosa) have beed described to improve fixation&#xD;
      (mimicking an open surgical anastomosis) during or after EVAR/TEVAR.&#xD;
&#xD;
      The investigators want to describe the outcomes of all consecutive patients treated with this&#xD;
      device (retrospective and prospective data - observational study)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      EndoAnchors (Heli-FX device, Medtronic, Santa Rosa) have beed designed to improve the&#xD;
      Endovascular aortic repair. This device is described to mimic an open surgical anastomosis&#xD;
      during or after EVAR/TEVAR.&#xD;
&#xD;
      The investigators want to describe the outcomes of all consecutive patients treated with this&#xD;
      device (retrospective and prospective data - observational study), these outcomes will be&#xD;
      described in terms of type IA Endoleaks, migration and sac regression.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 31, 2019</start_date>
  <completion_date type="Anticipated">November 19, 2022</completion_date>
  <primary_completion_date type="Actual">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>36 Months</target_duration>
  <primary_outcome>
    <measure>Rate of participants with type IA Endoleaks</measure>
    <time_frame>Three years</time_frame>
    <description>Absence of type IA Endoleaks during follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with Endograft Migration</measure>
    <time_frame>Three years</time_frame>
    <description>Analysis of Endograft migration during follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with Sac regression</measure>
    <time_frame>Three years</time_frame>
    <description>Analysis of Sac regression during follow-up</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Aortic Aneurysm</condition>
  <condition>Thoracic Aortic Aneurysm</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ESAR (Endosutured Aneurysm Repair)</intervention_name>
    <description>EndoAnchors adjunctive therapy for EVAR and TEVAR</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with abdominal or thoracic aneurysms.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All consecutive patients with adjunctive use of EndoAnchors during or after EVAR and&#xD;
             TEVAR&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients that don't want te receive any repair for their disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andres Reyes Valdivia, Consultant</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vascular Surgery Department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andres Reyes Valdivia, Consultant</last_name>
    <phone>+34629586239</phone>
    <email>cauzaza@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Vascular Surgery Department</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrés Reyes, Consultant</last_name>
      <phone>+34629586239</phone>
      <email>cauzaza@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Reyes Valdivia A, Duque Santos Á, Pitoulias G, Aracil Sanus E, Ocaña Guaita J, Gandarias Zúñiga C. Predictors of inadequate EndoAnchors aortic wall penetration for the Endosutured therapy in hostile neck patients. J Cardiovasc Surg (Torino). 2020 Dec;61(6):738-744. doi: 10.23736/S0021-9509.20.11248-5. Epub 2020 Jun 19.</citation>
    <PMID>32558525</PMID>
  </reference>
  <reference>
    <citation>Reyes Valdivia A, Busto Suárez S, Duque Santos Á, Zanabili Al-Sibbai AA, Gandarias Zúñiga C, Chaudhuri A. Evaluation of EndoAnchor Aortic Wall Penetration After Thoracic Endovascular Aortic Repair. J Endovasc Ther. 2020 Apr;27(2):240-247. doi: 10.1177/1526602820907564.</citation>
    <PMID>32186262</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>September 19, 2019</study_first_submitted>
  <study_first_submitted_qc>September 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2019</study_first_posted>
  <last_update_submitted>February 8, 2021</last_update_submitted>
  <last_update_submitted_qc>February 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Ramon y Cajal</investigator_affiliation>
    <investigator_full_name>Andrés Reyes Valdivia</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Endoanchors</keyword>
  <keyword>EVAR</keyword>
  <keyword>TEVAR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Thoracic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

